Список литературы

1. Sloan B, Scheinfeld N. The use and safety of doxycycline hyclate and other Second generation tetracyclines. Expert opinion on drug safety 2008 Sep; 7(5): 5717.

2. Waites KB, Crabb DM, Duffy LB. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101. Antimicrobial agents and chemotherapy 2009 May; 53(5): 2139 - 41.

3. Guangyong Ye, Zhou Jiang, Min Wang, Jiamin Huang, Guochen Jin. The Resistance Analysis of Ureaplasma urealyticum and Mycoplasma hominis in Female Reproductive Tract Specimens Shiming Lu Cell Biochem Biophys DOI 10.1007/s12013-013-9691-8.

4. Zhou Jiang, Min Wang, Jiamin Huang, Guochen Jin, Shiming Lu. Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Jun; 25(3): 201 - 4.

5. Sonia Caracciolo, Carlo Bonfanti, Nino Manca, Maria Antonia De Francesco. Incidence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum isolated in Brescia, Italy, over 7 years. J Infect Chemother DOI 10.1007/s10156-012-0527-z.

6. Lysenko O.V., Kuznechenkova T.V., Iglikov V.A., Deryabina V.P. Prevalence of urogenital inflammatory diseases associated with genital mycoplasmas. treatment efficacy. Vest Dermatol Venerol 2010; 83 - 88.

7. Leli C, Mencacci A, Bombaci JC, D"Alo F, Farinelli S, Vitali M, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a population of Italian and immigrant outpatients. Infez Med 2012; 20: 82 - 87.

8. Zhu C, Liu J, Ling Y, Dong C, Wu T, Yu X, et al. Prevalence and antimicrobial susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Chinese women with genital infectious diseases. Indian J Dermatol Venereol Leprol 2012; 78: 406 - 407.

9. Farkas B, Ostorhazi E, Ponyai K, Toth B, Adlan E, Parducz L, et al. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals]. Orv Hetil 2011; 152: 1698 - 1702.

10. Krausse R, Schubert S. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years. Clin Microbiol Infect 2010; 16: 1649 - 1655.

11. Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H, Batislam E. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis 2004, 57: 17 - 20.

12. Ruairi Conway, Seamus Cook, Suneeta Soni. Antibiotic treatment of Mycoplasma genitalium infection. The Pharmaceutical Journal. 2019. Vol 303, No 7928, online | DOI: 10.1211/PJ.2019.20206592

13. Кубанова А.А., Рахматулина М.Р. Урогенитальные инфекционные заболевания, вызванные генитальными микоплазмами. Клинические рекомендации. Вестник дерматологии и венерологии. 2009. - N 3. - С. 78 - 84.

14. Рахматулина М.Р. Урогенитальные заболевания, вызванные генитальными микоплазмами (Mycoplasma genitalium, Ureaplasma spp., Mycoplasma hominis) Consilium medicum, 2012; N 2: C. 22 - 25.

15. Eunha Koh, Sunjoo Kim, In-Suk Kim, Kook-Young Maeng, Soon-Ae Lee Antimicrobial Susceptibilities of Ureaplasma urealyticum and Mycoplasma hominis in Pregnant Women Korean J Clin Microbiol, 2009; Vol. 12, No. 4.

16. Seong Jin Choi, M.D., Soon Deok Park, M.S., In Ho Jang, M.S., Young Uh, M.D., Anna Lee, M.D The Prevalence of Vaginal Microorganisms in Pregnant Women with Preterm Labor and Preterm Birth Ann Lab Med, 2012 May; 32(3): 194 - 200.

17. Mehmet Bayraktar, Ibrahim Halil Ozerol, Nilay Gucluer, Onder Celik. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women International Journal of Infectious Diseases, 2010; 14: 90 - 95.

18. Mroczkowsky TF, Mena L, Nsuami M, Martin DH. A randomized comparisonof azithromycin and doxycycline for the treatment of Mycoplasma genitalium (MG) positive urethritis. 16th Biennial Meeting of the International Society of Sexually Transmitted Disease (ISSTDR), Amsterdam, The Netherlands 2005; 304 - 305.

19. Wikstrom A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006; 82(4): 276 - 279.

20. Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48: 1649 - 54. 4

21. Guschin A, Ryzhikh P, Rumyantseva T, Gomberg M, Unemo M. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin. BMC Infect Dis. 2015 Feb 3; 15: 40.

22. Andreeva IV, Kozlov SN, Korolev SV, Belikov AN, Grinev AV, Evstaf"ev VV, Kirpicheva NN, Serdiutskaia MV, Stetsiuk OU, Fokin AA, Khrianin AA. Diagnostic and treatment patterns in management of male patients with nongonococcal urethritis: results of Russian multicentral cross-sectional study. Antibiot Khimioter. 2012; 57(5-6): 32 - 40.

23. Guo X., Ye Z., Deng R. Male urogenital tract mycoplasma infection and drug-resistance evolution. Josamycin - das bessere Makrolid? Zhonghua Nan Ke Xue 10(2) (2004) 122 - 124.

24. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for Microbiological cure of Mycoplasma genitalium infection: an open study. International journal of STD & AIDS 2008 Oct; 19(10): 676 - 9.

25. Ross JD, Cronje HS, Paszkowski T, et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect 2006; 82: 446 - 51.

26. MMWR Recommendations and Reports/Vol. 64/No. 3 June 5, 2015/.Sexually Transmitted Diseases Treatment Guidelines, 2015.

27. Czeizel AE, Rockenbauer M, Olsen J, HT. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand. 2000 Mar; 79(3): 234 - 7.

28. Юрьев С., Аббасова В.И., Девятьярова Л.Л., Гущин А.Е. К вопросу о специфичности влияния Mycoplasma genitalium на течение беременности. Гинекология 2009; N 4: 20 - 3

29. Рахматулина М.Р., Касаткина И.С. Современные представления о роли генитальных микоплазм в развитии патологических процессов урогенитальной системы, методах их диагностики и лечения у детей. Вестник дерматологии и венерологии. - 2011. - N 1 - С. 15 - 23.

30. Charlotte A GaydosJ Infect Dis. Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment 2017 Jul 15; 216 (Suppl 2): S406 - S411. doi: 10.1093/infdis/jix104.

31. Coorevits, L.; Traen, A. , L. et al. Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalism and human papillomavirus. Clin Microbiol Infect. 2018 Mar 17.pii: S1198-743X (18) 30223-4. DOI: 10.1016/j.cmi.2018.03.013.

32. Zhonghua Liu, Jun Wang, Changtai Zhu Clinical Practice Guidelines for the Diagnosis and Treatment of Ureaplasma Urealyticum Infections are NeededAustin Clin Microbiol. 2016; 1(1): 1001.

33. Couldwell DL, Gidding HF, Freedman EV, et al. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS 2010; 21: 337.

34. Deguchi T, Shimada Y, Horie K, et al. Bacterial loads of Ureaplasma parvum contribute to the development of inflammatory responses in the male urethra. Int J STD AIDS 2015; 26: 1035.

35. Murtha AP, Edwards JM. The role of Mycoplasma and Ureaplasma in adverse pregnancy outcomes. Obstet Gynecol Clin North Am 2014; 41: 615.

36. Sleha R, V, Hampl R, et al. Prevalence of Mycoplasma hominis and Ureaplasma urealyticum in women undergoing an initial infertility evaluation. Epidemiol Mikrobiol Imunol Fall; 65: 232.

37. Wei-Na Li, Wen-Bing Zhu, Gang Liu [Correlation of Mycoplasma genitalium infection with male infertility] [Article in Chinese]. Zhonghua Nan Ke Xue; 2018 Nov; 24(11): 999 - 1004.

38. Vouga M, Greub G, Prod"hom G, et al. Treatment of genital mycoplasma in colonized pregnant women in late pregnancy is associated with a lower rate of premature labour and neonatal complications. Clin Microbiol Infect 2014; 20: 1074.

39. Sunil Sethi, Kamran Zaman, and Neha Jain Mycoplasma genitalium infections: current treatment options and resistance issues Infect Drug Resist. 2017; 10: 283 - 292.

40. Mahlangu MP, EE, Venter JME et al. The Prevalence of Mycoplasma genitalium and Association With Human Immunodeficiency Virus Infection in Symptomatic Patients, Johannesburg, South Africa, 2007 - 2014. Sex Transm Dis. 2019 Jun; 46(6): 395 - 399. doi: 10.1097/OLQ.0000000000000984.

41. Chra P, Papaparaskevas J, Papadogeorgaki E Prevalence of Mycoplasma genitalium and other sexually-transmitted pathogens among high-risk individuals in Greece. Germs. 2018 Mar 1; 8(1): 12 - 20. doi: 10.18683/germs.2018.1128. eCollection 2018 Mar.

42. Инфекции, передаваемые половым путем. Кисина В.И., Гущин А.Е., Забиров К.И. М., ГЭОТАР-Медиа, 2020 г., с 144.

43. Инфекции, передаваемые половым путем. Руководство для врачей. Соколовский Е.В., Савичева А.М., Домейка М. Москва, Медпресс-информ, 2006.

44. 2015 Sexually Transmitted Diseases Treatment Guidelines. Centers for diseases control and pre-vention. MMWR Vol 64/N3, June 5, 2015.

45. 62-Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J EurAcadDermatolVenereol. 2016; 30: 1650 - 1656. https://doi.org/10.1111/jdv.13849.

46. 63-Li Y, Le W-J, Li S, et al. Meta-analysis of the of in treating Mycoplasma genitalium infection. Int J STD AIDS 2017; 28: 1106 - 1114.

47. Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: A meta-analysis. Clin Infect Dis. 2015 Apr; 61: 418 - 426. https://doi.org/10.1093/cid/civ312.

48. Chrisment D, Machelart I, Wirth G. Reactive arthritis associated with Mycoplasma genitalium urethritis. Diagn Microbiol Infect Dis. 2013 Nov; 77(3): 278 - 9. doi: 10.1016/j.diagmicrobio.2013.07.015. Epub 2013 Sep 10.

49. Johnson S, Pitcher D. Distribution of ecto 5"-nucleotidase on Mycoplasma species associated with arthritis. FEMSMicrobiolLett. 2000 Nov 1; 192(1): 59 - 65.

50. Henry C.H., Hughes C.V., H.C., Hudson A.P., Wolford L.M. Reactive arthritis: preliminary microbiologic analysis of human temporomandibular joint. J. Oral Maxillofac. Surg. 2000. Vol. 58, N 10. P. 1137 - 1142. https://doi.org/10.1053/joms.2000.9575.

51. Doble A., et al. A search for infectious agents in chronic abacterial prostatitis using ultrasound guided biopsy. Br. J. Urol. 1989. 64: 297 - 301. https://doi.org/10.1111/j.1464-410x.1989.tb06017.x.

52. Krieger J. N., Riley D. E., Roberts M. C., Berger R. E. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis. J. Clin. Microbiol. 1996. 34: 3120 - 3128. https://doi.org/10.1016/b978-0-08-025494-4.50020-6.

53. Mandar R., Raukas E., Turk S., Korrovits P., Punab M. Mycoplasmas in semen of chronic prostatitis patients. Scand. J. Urol. Nephrol. 2005. 39: 479 - 482. https://doi.org/10.1080/00365590500199822.

54. Datta S, Mercer CH, Keeling MJ. et al. Capturing sexual contact patterns in modelling the spread of sexually transmitted infections: Evidence using Natsal-3. PLoS One. 2018 Nov 1; 13(11): e0206501. doi: 10.1371/journal.pone.0206501. eCollection 2018.

55. Mathews C, Kalichman MO, Laubscher R et al. Sexual relationships, intimate partner violence and STI partner notification in Cape Town, South Africa: an observational study. Sex Transm Infect. 2018 Mar; 94(2): 144 - 150. doi: 10.1136/sextrans-2017-053434. Epub 2017 Nov 30.

56. Савичева А.М., Прилепская М.В., Соколовский Е.В., Кисина В.И., Гущин А.Е., Забиров К.И. Роль микоплазм в урогенитальной патологии женщин и их половых партнеров. Журнал акушерства и женских болезней. Том LVII, выпуск 1 (2008). с. 11 - 22.

57. Рахматулина М.Р. Тактика диагностики и терапии урогенитальной микоплазменной инфекции согласно Федеральным клиническим рекомендациям. Фарматека 2016. N 3. с. 33 - 38.

58. Г.И. Мавров, Т.В. Федорович. Урогенитальный микоплазмоз: непростой выбор антибактериальной терапии (обзор литературы и собственные исследования). Украинский журнал дерматологии, венерологии и косметологии. 2016. 1 (60).

59. Lars Falk, Martin Enger, Skov Jensen. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women. Journal of Antimicrobial Chemotherapy, Volume 70, Issue 11, November 2015, Pages 3134 - 3140, https://doi.org/10.1093/jac/dkv246.

60. В.И. Кисина. Генитальные микоплазмы: клинические и организационные вопросы. Дерматология N 2. 2010. Приложение consilium medicum. с 42 - 47.

61. Anagrius C., Lore B., Jensen J. S. Mycoplasma genitalium: prevalence, clinical significance, and transmission//Sexually transmitted infections. - 2005. - Т. 81. - N. 6. - С. 458 - 462.

62. Wroblewski J. K. H. et al. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium//Journal of clinical microbiology. - 2006. - Т. 44. - N. 9. - С. 3306 - 3312.

63. Carlsen K. H., Jensen J. S. Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity?//Journal of Clinical Microbiology. - 2010. - Т. 48. - N. 10. - С. 3624 - 3627.

64. GM Daley, DB Russell, SN Tabrizi. Mycoplasmagenitalium: areview//IntJSTDAIDS. 2014 Jun; 25(7): 475 - 87. doi: 10.1177/0956462413515196.

65. Васильев М.М., Наволоцкая Т.И., Смирнова А.А., Фриго Н.В., Ротанов С.В., Сидорович С.Ю. Применение джозамицина (вильпрафена) у женщин с хламидийной инфекцией нижних и верхних отделов мочеполового тракта. Вестник дерматологии и венерологии 2005; (3): 78 - 80.

66. И.О. Малова, Т.Г. Храмова. Эффективность джозамицина у девочек с урогенитальной инфекцией, вызванной Mycoplasma genitalium "Эффективная фармакотерапия. Акушерство и Гинекология" N 4. 2007.

67. Рахматулина М.Р. Урогенитальные заболевания, вызванные генитальными микоплазмами. CONSILIUM MEDICUM. 2012. - N 2. Репринт. С. 2 - 6.

68. В.Н. Кузьмин, М.И. Гусейнзаде. Эффективная антибактериальная терапия микоплазменной инфекции у женщин репродуктивного возраста. Лечащий врач. - 2014. - N 3